The endoscopic finding of ileal ulcers, alone or in small number, is not usual, but when it occurs in asymptomatic patients, an impasse may be generated regarding the action to be taken, since the medical literature is unclear as to how to proceed in this situation. Objective: Evaluate patients with ileal ulcers, single or in a small number, asymptomatic, and their follow-up. Methods: The author reports a series of asymptomatic cases (23 patients) of ulcers -single or in small number -found in colonoscopy exams performed for other reasons than typical clinical manifestations of Crohn's disease. Results: Most patients were not treated and remained asymptomatic during the follow-up period.
INTRODUCTION
One patient, at the return appointment, brought a colonoscopy exam showing one or more small ulcers in the terminal ileum, and such finding was a surprise, considering that the reasons for the exam did not include the suspicion of Crohn's disease (DC). Having discarded the other causes for these ulcers, but, without a convincing histopathological confirmation, how should we proceed? While the patient waits for a definition regarding the diagnosis and the treatment to be adopted, many questions are agitating the assistant physician's mind in this situation. Is it really CD? If the patient is asymptomatic, is it correct to start a treatment with possible adverse effects and for undetermined period? If the option is not treating the patient, wouldn't we be allowing the disease to develop and maybe appear in the future in more severe forms?
The situation described in this study has certainly occurred or will occur one day to physicians dedicated to the treatment of intestinal inflammatory diseases (IID). It is one of the various challenging situations related to IID that we should face in the daily practice and whose answers are vague in the current medical literature. 
OBJECTIVE
Evaluate patients with ileal ulcers, single or in a small number, asymptomatic, and their follow-up.
METHODS
The author reports a case series of patients without CD symptoms, but presenting ileal ulcers at colonoscopy. The records of all patients (all adults) were retrospectively analyzed, regarding gender, age, symptoms and/or factors that required the colonoscopy exam, number of ulcers at colonoscopy, indication or non indication of treatment and follow-up. The study excluded patients that had recently used nonsteroidal anti-inflammatory drugs and those with lesions, signs and/or symptoms suggestive of other specific diseases.
RESULTS

From February 9, 2004 to July 1 st
, 2011, the study analyzed 23 asymptomatic patients (11 male patients, 27 to 74 years old, mean age: 48 years old), whose colonoscopy exam presented ileal ulcers, not including here those patients that had recently used non-steroidal anti-inflammatory drugs and those with lesions suggestive of any specific diseases.
The patients' clinical conditions were not at first suggestive of CD; thus, the indications for colonoscopy were varied, and the endoscopic findings were not compatible with initial signs or symptoms. That was the main aspect that led to the description of this case series. The indications for colonoscopy included: hematochezia, pain and abdominal distension, as well as anal pain (Table 1) .
Regarding the endoscopic findings, ileal ulcers were found, single or in small number, with biopsy performed for the histological analysis, which resulted in unspecific inflammatory process in all cases (Table 2) . One patient presented diverticular disease in the sigmoid colon and one patient presented hemorrhoidal disease. No other concomitant finding was reported.
All 23 patients received explanations about the possible diagnosis, including the hypothesis of CD, and about the clinical treatment to be adopted. Only four of them decided to take the treatment. Two patients were prescribed mesalazine 3 g/day and two patients, azathioprine 150 mg/day. Mesalazine was prescribed in the first cases, of 2004 and 2006, when it was the standard treatment. For more recent cases, the option was azathioprine, according to current protocols.
Among the four treated patients, one (treated with mesalazine) did not come back and was not found for a new evaluation. The other three patients were reevaluated six months later. One of them (treated with mesalazine) started to present symptoms compatible with CD, the ileal ulcer remained and the treatment had to be altered. Today, this patient is asymptomatic, taking azathioprine. Another patient continues asymptomatic, but with ileal ulcer at colonoscopy. The treatment was interrupted and the patient has been under observation. And the other patient remained asymptomatic, but presented mild colitis at control colonoscopy, and for this reason, is still taking the treatment with azathioprine.
Among the 19 patients who did not decide to take the treatment, 8 have not returned and 11 were reevaluated, initially within 6 months on average, and these patients remained asymptomatic. One patient of this group was submitted to a surgery due to anal fistula and presented good progress. Control colonoscopy was performed and six of them still presented ileal ulcers, with the same initial characteristics. Thus, the option was to keep these 11 patients without treatment and under clinical observation (Table 3) .
DISCUSSION
The literature has few articles addressing this situation of asymptomatic patients with ileal lesions compatible with CD. After discarding differential diagnoses, such as intestinal tuberculosis, ulcers related to the use of non-hormonal anti-inflammatory agents and opportunistic diseases, CD appeared as a very probable hypothesis. Histopathological findings of colonoscopic biopsy are not usually conclusive for CD diagnosis when analyzed individually. The collected material is often representative of the mucosa only, with unspecific inflammatory alterations that do not allow the pathologist to define the diagnosis 1 . That does not enable a fully satisfactory answer when we ask if single ileal ulcers in asymptomatic individuals are really manifestations of CD. If we consider that this is the probable diagnosis, how should be proceed?
Today, many specialists defend the idea of complete remission with the treatment of CD to prevent recurrence or the development of severe forms of the disease. In this sense, it sounds reasonable to prescribe the treatment to patients in the situation reported in this article. On the other hand, how to convince an asymptomatic patient to use drugs that may cause side effects and especially for undetermined period? The option in the cases of this study was to share with patients the decision on whether to take the treatment or not. As clearly demonstrated, most patients are not encouraged to take a treatment without a certain diagnosis, and especially without any symptom. Perhaps, this is the proper practice, as the follow-up of these patients showed that most of them
